Position in GILD
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,357,966
+$4,305,844 QoQ
Shares Held
89,900
+77.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#411
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTACT INVESTMENT MANAGEMENT INC. holds $106,940,186 across 8 Drug Manufacturers - General names. GILD ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
202,100 | $25,969,850 | |
| 2 | ABBV |
AbbVie Inc.
|
95,230 | $23,963,677 | |
| 3 | JNJ |
Johnson & Johnson
|
64,629 | $16,413,827 | |
| 4 | PFE |
Pfizer Inc
|
679,300 | $16,357,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
89,900 | $11,357,966 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
148,700 | $8,568,094 | |
| 7 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 | |
| 8 | LLY |
ELI LILLY & Co
|
0 | $0 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,357,966 | 89,900 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,052,122 | 50,600 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,359,256 | 84,400 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $4,639,800 | 41,800 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $4,601,105 | 41,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,131,890 | 45,800 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,239,783 | 45,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $11,687,296 | 139,400 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $9,584,817 | 139,700 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,328,800 | 86,400 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $10,004,735 | 123,500 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $9,255,090 | 123,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,593,305 | 111,500 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $12,876,944 | 155,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,026,975 | 93,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,010,421 | 210,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,646,326 | 204,600 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,032,680 | 202,400 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,229,938 | 85,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,993,130 | 85,800 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,908,188 | 85,800 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,545,254 | 85,800 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,955,854 | 67,900 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $4,290,601 | 67,900 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,347,110 | 56,500 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $9,905,700 | 132,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||